Showing 970 results for "sarcoidosis"

Phase 2 Trial of Inhaled Therapy Aviptadil OK’d in Germany

A Phase 2 clinical trial investigating the inhaled sarcoidosis therapy aviptadil — also known as RLF-100, and designed to block inflammation in the lungs — has been cleared to start in Germany. The clearance by the German medical regulatory authority Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) was given to…

‘It’s Hard to Be What You Can’t See’

For those with sarcoidosis, one of the most challenging aspects of the disease is finding folks who are just like us. I’m not referring to race, gender, or any other characteristic that differentiates us as individuals. I’m talking about the things that make us the same. I’m talking about finding…

Researchers Seek Biomarkers to Predict ATYR1923’s Effectiveness

aTyr Pharma has announced a collaboration with The Ohio State University (OSU) to conduct cell culture studies seeking to identify potential biomarkers that can predict ATYR1923’s therapeutic effectiveness in people with pulmonary sarcoidosis. The research, which extends previous proof-of-concept findings, will delineate the pathways involved in sarcoid granuloma formation…

Asking ‘What If?’ Can Be Worse Than Failure

“Well, listen to your lungs.” Those were the first words from my doctor’s mouth, following his slight look of concern. It was early 2020, just before the COVID-19 pandemic began in the United States, and I had boldly (and perhaps foolishly) told him that I was running a half-marathon in…

Chronic Illness and Living a Life Without Compromise

“Blessed are the pure in heart, for they shall see God.” — Matthew 5:8 In 2017, my life took a turn I never expected. When something blindsides us, especially when it involves our health, sometimes we can interpret it as just an interruption in our lives. But most often, it’ll…